1. Inhibition of human p53 basal transcription by down-regulation of protein kinase Cdelta;Abbas;J Biol Chem,2004
2. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions;Ahomadegbe;Oncogene,1995
3. Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2–11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens;Balz;Cancer Res,2003
4. p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis;Bergamaschi;Cancer Cell,2003
5. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human;Bergamaschi;Nat Genet,2003